Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Drug Discov. 2010 Sep;9(9):719-27. doi: 10.1038/nrd3074. Epub 2010 Aug 20.

An insight into the antifungal pipeline: selected new molecules and beyond.

Author information

1
Division of Infectious Diseases, University of Texas Medical School at Houston, 6431 Fannin, MSB 2.112, Houston, Texas 77030, USA. Luis.Ostrosky-Zeichner@uth.tmc.edu

Abstract

Invasive fungal infections are increasing in incidence and are associated with substantial mortality. Improved diagnostics and the availability of new antifungals have revolutionized the field of medical mycology in the past decades. This Review focuses on recent developments in the antifungal pipeline, concentrating on promising candidates such as new azoles, polyenes and echinocandins, as well as agents such as nikkomycin Z and the sordarins. Developments in vaccines and antibody-based immunotherapy are also discussed. Few therapeutic products are currently in active development, and progression of therapeutic agents with fungus-specific mechanisms of action is of key importance.

PMID:
20725094
DOI:
10.1038/nrd3074
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center